مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer.
Normal view MARC view ISBD view

Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer. [electronic resource]

By:
  • Chudecka-Głaz, Anita Monika
Contributor(s):
  • Cymbaluk-Płoska, Aneta Alicja
  • Menkiszak, Janusz Leszek
  • Sompolska-Rzechuła, Agnieszka Monika
  • Tołoczko-Grabarek, Aleksandra Izabela
  • Rzepka-Górska, Izabella Anna
Producer: 20150221Description: 62 p. digitalISSN:
  • 1757-2215
Subject(s):
  • Adipokines -- blood
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
  • Biomarkers, Tumor -- blood
  • CA-125 Antigen -- blood
  • Cathepsin L -- blood
  • Chitinase-3-Like Protein 1
  • Cytoreduction Surgical Procedures
  • Female
  • Humans
  • Lectins -- blood
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Staging
  • Ovarian Neoplasms -- blood
  • Preoperative Period
  • Prognosis
  • Proteins
  • Proto-Oncogene Proteins c-bcl-2 -- blood
  • ROC Curve
  • Reproducibility of Results
  • Treatment Outcome
  • WAP Four-Disulfide Core Domain Protein 2
Online resources:
  • Available from publisher's website
In: Journal of ovarian research vol. 7
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.

Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer.

APA

Chudecka-Głaz A. M., Cymbaluk-Płoska A. A., Menkiszak J. L., Sompolska-Rzechuła A. M., Tołoczko-Grabarek A. I. & Rzepka-Górska I. A. (20150221). Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer. : Journal of ovarian research.

Chicago

Chudecka-Głaz Anita Monika, Cymbaluk-Płoska Aneta Alicja, Menkiszak Janusz Leszek, Sompolska-Rzechuła Agnieszka Monika, Tołoczko-Grabarek Aleksandra Izabela and Rzepka-Górska Izabella Anna. 20150221. Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer. : Journal of ovarian research.

Harvard

Chudecka-Głaz A. M., Cymbaluk-Płoska A. A., Menkiszak J. L., Sompolska-Rzechuła A. M., Tołoczko-Grabarek A. I. and Rzepka-Górska I. A. (20150221). Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer. : Journal of ovarian research.

MLA

Chudecka-Głaz Anita Monika, Cymbaluk-Płoska Aneta Alicja, Menkiszak Janusz Leszek, Sompolska-Rzechuła Agnieszka Monika, Tołoczko-Grabarek Aleksandra Izabela and Rzepka-Górska Izabella Anna. Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer. : Journal of ovarian research. 20150221.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site